Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 16 items for :

  • Refine by access: All content x
Clear All
Nely Díaz-Mejía Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Nely Díaz-Mejía in
Google Scholar
PubMed Close
,
David García-Illescas Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by David García-Illescas in
Google Scholar
PubMed Close
,
Rafael Morales-Barrera Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Rafael Morales-Barrera in
Google Scholar
PubMed Close
,
Cristina Suarez Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Cristina Suarez in
Google Scholar
PubMed Close
,
Jacques Planas Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Jacques Planas in
Google Scholar
PubMed Close
,
Xavier Maldonado Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Xavier Maldonado in
Google Scholar
PubMed Close
,
Joan Carles Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Joan Carles in
Google Scholar
PubMed Close
, and
Joaquin Mateo Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron University Hospital, Barcelona, Spain

Search for other papers by Joaquin Mateo in
Google Scholar
PubMed Close

. 2020 b ). Moreover, a recent study comparing primary tumor biopsies and cfDNA samples acquired later at the time of mCRPC also confirmed that BRCA2, ATM and CDK12 defects are already present in the primary tumors of these patients ( Warner et al

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-21-0133
Volume/Issue:
Volume 28: Issue 8
Free access
Darren Cowzer Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Darren Cowzer in
Google Scholar
PubMed Close
,
Ronak H Shah Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Ronak H Shah in
Google Scholar
PubMed Close
,
Joanne F Chou Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Joanne F Chou in
Google Scholar
PubMed Close
,
Ritika Kundra Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Ritika Kundra in
Google Scholar
PubMed Close
,
Sippy Punn Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Sippy Punn in
Google Scholar
PubMed Close
,
Laura Fiedler Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Laura Fiedler in
Google Scholar
PubMed Close
,
April DeMore Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by April DeMore in
Google Scholar
PubMed Close
,
Marinela Capanu Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Marinela Capanu in
Google Scholar
PubMed Close
,
Michael F Berger Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Department of Pathology and laboratory medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Michael F Berger in
Google Scholar
PubMed Close
,
Diane Reidy-Lagunes Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Weill Medical College of Cornell University, New York, New York, USA

Search for other papers by Diane Reidy-Lagunes in
Google Scholar
PubMed Close
, and
Nitya Raj Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Weill Medical College of Cornell University, New York, New York, USA

Search for other papers by Nitya Raj in
Google Scholar
PubMed Close

well-differentiated tumors, while RB1 loss is exclusive to poorly differentiated tumors, and altered TP53 is seen across the spectrum of NENs. Tumor-derived cell free DNA (cfDNA) detection in plasma provides the opportunity to potentially conduct

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-23-0292
Volume/Issue:
Volume 31: Issue 4
Restricted access
Mark Daniel Masonic Cancer Center, University of Minnesota
Graduate Program in Microbiology, Immunology, and Cancer Biology, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Mark Daniel in
Google Scholar
PubMed Close
,
Todd P Knutson University of Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Todd P Knutson in
Google Scholar
PubMed Close
,
Jamie M Sperger Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA
Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Jamie M Sperger in
Google Scholar
PubMed Close
,
Yingming Li Masonic Cancer Center, University of Minnesota

Search for other papers by Yingming Li in
Google Scholar
PubMed Close
,
Anupama Singh Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Anupama Singh in
Google Scholar
PubMed Close
,
Charlotte N Stahlfeld Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA
Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Charlotte N Stahlfeld in
Google Scholar
PubMed Close
,
Courtney Passow University of Minnesota Genomics Center, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Courtney Passow in
Google Scholar
PubMed Close
,
Benjamin Auch University of Minnesota Genomics Center, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Benjamin Auch in
Google Scholar
PubMed Close
,
Joshua M Lang Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA
Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA

Search for other papers by Joshua M Lang in
Google Scholar
PubMed Close
, and
Scott M Dehm Masonic Cancer Center, University of Minnesota
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA
Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Scott M Dehm in
Google Scholar
PubMed Close

tumors by identifying tumor-associated copy number alterations, mutations, and structural variants in plasma cell-free DNA (cfDNA). Targeted DNA-seq profiling of cfDNA and paired tissue biopsies in CRPC patients have shown that genomic alterations in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-21-0157
Volume/Issue:
Volume 28: Issue 9
Restricted access
Himisha Beltran Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

Search for other papers by Himisha Beltran in
Google Scholar
PubMed Close
and
Francesca Demichelis Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy

Search for other papers by Francesca Demichelis in
Google Scholar
PubMed Close

-invasive biomarkers have an additional advantage in more accurately reflecting composite tumor burden and molecular intra-patient heterogeneity. Especially in the setting of heterogeneous diseases such as metastatic prostate cancer, plasma cell-free DNA (cfDNA

Article Type:
Review Article
Collections:
Top-cited articles of 2023
DOI:
https://doi.org/10.1530/ERC-21-0140
Volume/Issue:
Volume 28: Issue 8
Free access
Walid Zeyghami Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, University Hospital Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Walid Zeyghami in
Google Scholar
PubMed Close
,
Marie-Louise Uhre Hansen Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, University Hospital Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Marie-Louise Uhre Hansen in
Google Scholar
PubMed Close
,
Kathrine Kronberg Jakobsen Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, University Hospital Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Kathrine Kronberg Jakobsen in
Google Scholar
PubMed Close
,
Christian Groenhøj Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, University Hospital Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Christian Groenhøj in
Google Scholar
PubMed Close
,
Ulla Feldt-Rasmussen Department of Endocrinology, University Hospital Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Clinical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed Close
,
Christian von Buchwald Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, University Hospital Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Clinical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Christian von Buchwald in
Google Scholar
PubMed Close
, and
Christoffer Holst Hahn Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, University Hospital Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Christoffer Holst Hahn in
Google Scholar
PubMed Close

released from the primary tumors such as circulating tumor cells (CTCs) or cell-free DNA (cfDNA) ( Fig. 1 ). Several techniques have been developed to detect liquid biopsies ( Palmirotta et al. 2018 , Lone et al. 2022 ). The increased release of cfDNA

Article Type:
Systematic Review
DOI:
https://doi.org/10.1530/ERC-23-0002
Volume/Issue:
Volume 30: Issue 12
Free access
Laura Gerard Service de Gastroentérologie et d’Oncologie Médicale, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France
Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Laura Gerard in
Google Scholar
PubMed Close
,
Céline Patte Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Céline Patte in
Google Scholar
PubMed Close
,
Laurence Chardon Service de Biochimie Biologie Moléculaire, Centre de Biologie Est, Hospices Civils de Lyon, Bron, France

Search for other papers by Laurence Chardon in
Google Scholar
PubMed Close
,
Valérie Hervieu Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France
Service Central d’Anatomie et Cytologie Pathologiques, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France

Search for other papers by Valérie Hervieu in
Google Scholar
PubMed Close
,
Léa Payen Institut de Cancérologie des Hospices Civils de Lyon, CIRculating CANcer Program (CIRCAN), Lyon, France

Search for other papers by Léa Payen in
Google Scholar
PubMed Close
,
Marion Allio Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Marion Allio in
Google Scholar
PubMed Close
,
Claire Marx Service d'Endocrinologie-Diabète-Nutrition, Hospices Civils de Lyon, Hôpital Lyon Sud, Lyon, France

Search for other papers by Claire Marx in
Google Scholar
PubMed Close
,
Hugo Clermidy Service de Chirurgie Thoracique, Vidéothoracoscopie et Transplantation Pulmonaire, Hospices Civils de Lyon, Hôpital Louis Pradel, Lyon, France

Search for other papers by Hugo Clermidy in
Google Scholar
PubMed Close
,
Alice Durand Service de Gastroentérologie et d’Oncologie Médicale, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France

Search for other papers by Alice Durand in
Google Scholar
PubMed Close
,
Patrick Mehlen Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Patrick Mehlen in
Google Scholar
PubMed Close
,
Julien Bollard Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Julien Bollard in
Google Scholar
PubMed Close
,
Gilles Poncet Service de Chirurgie Digestive, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France

Search for other papers by Gilles Poncet in
Google Scholar
PubMed Close
,
Colette Roche Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Colette Roche in
Google Scholar
PubMed Close
,
Benjamin Gibert Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Benjamin Gibert in
Google Scholar
PubMed Close
, and
Thomas Walter Service de Gastroentérologie et d’Oncologie Médicale, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France
Gastroenterology and Technologies for Health, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Lyon, France

Search for other papers by Thomas Walter in
Google Scholar
PubMed Close

. 2021 ). In patients with cancer, the circulating tumour DNA (ctDNA) originates from tumour cells and represents a small fraction of circulating cell-free DNA (cfDNA). It can reflect the tumour mutational burden and is correlated with disease course in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-24-0052
Volume/Issue:
Volume 31: Issue 6
Restricted access
Conleth G Murphy Bons Secours Hospital Cork, Medical Oncology, Cork, Ireland
University College Cork, Medicine, Cork, Ireland

Search for other papers by Conleth G Murphy in
Google Scholar
PubMed Close
and
Maura N Dickler Memorial Sloan-Kettering Cancer Center, Breast Medicine Service, New York, New York, USA
Joan and Sanford I Weill Medical College of Cornell University, Medicine, New York, New York, USA

Search for other papers by Maura N Dickler in
Google Scholar
PubMed Close

in BOLERO-2 was independent of PIK3CA mutational status as well as alterations of other closely related genes ( PTEN ) and pathways ( Hortobagyi et al. 2015 ). Subsequent analysis of cell-free DNA (cfDNA) extracted from archival plasma samples

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-16-0121
Volume/Issue:
Volume 23: Issue 8
Free access
Marion T Weigel The Institute of Cancer Research, Royal Marsden Hospital, Breakthrough Breast Cancer Research Centre, 237 Fulham Road, London SW3 6JB, UK

Search for other papers by Marion T Weigel in
Google Scholar
PubMed Close
and
Mitch Dowsett The Institute of Cancer Research, Royal Marsden Hospital, Breakthrough Breast Cancer Research Centre, 237 Fulham Road, London SW3 6JB, UK
The Institute of Cancer Research, Royal Marsden Hospital, Breakthrough Breast Cancer Research Centre, 237 Fulham Road, London SW3 6JB, UK

Search for other papers by Mitch Dowsett in
Google Scholar
PubMed Close

to meet the expectations is the identification of specific biomarkers on the CTCs, e.g. HER2 ( Fehm et al . 2005 ). Another possible approach to improve simplifying breast cancer management is the study of circulating cell-free DNA (cfDNA). This may

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-10-0136
Volume/Issue:
Volume 17: Issue 4
Free access
Alexa Childs Department of Oncology, Royal Free London NHS Foundation Trust, London, UK

Search for other papers by Alexa Childs in
Google Scholar
PubMed Close
,
Amy Kirkwood Cancer Research UK & UCL Cancer Trials Centre, London, UK

Search for other papers by Amy Kirkwood in
Google Scholar
PubMed Close
,
Julien Edeline UCL Cancer Institute, UCL, London, UK

Search for other papers by Julien Edeline in
Google Scholar
PubMed Close
,
Tu Vinh Luong Department of Pathology, Royal Free London NHS Foundation Trust, London, UK

Search for other papers by Tu Vinh Luong in
Google Scholar
PubMed Close
,
Jennifer Watkins Department of Pathology, Royal Free London NHS Foundation Trust, London, UK

Search for other papers by Jennifer Watkins in
Google Scholar
PubMed Close
,
Angela Lamarca Institute of Cancer Sciences, University of Manchester/The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Angela Lamarca in
Google Scholar
PubMed Close
,
Doraid Alrifai King’s College Hospital NHS Foundation Trust, London, UK

Search for other papers by Doraid Alrifai in
Google Scholar
PubMed Close
,
Phyllis Nsiah-Sarbeng Department of Radiology, Royal Free London NHS Foundation Trust, London, UK

Search for other papers by Phyllis Nsiah-Sarbeng in
Google Scholar
PubMed Close
,
Roopinder Gillmore Department of Oncology, Royal Free London NHS Foundation Trust, London, UK

Search for other papers by Roopinder Gillmore in
Google Scholar
PubMed Close
,
Astrid Mayer Department of Oncology, Royal Free London NHS Foundation Trust, London, UK

Search for other papers by Astrid Mayer in
Google Scholar
PubMed Close
,
Christina Thirlwell Department of Oncology, Royal Free London NHS Foundation Trust, London, UK
UCL Cancer Institute, UCL, London, UK

Search for other papers by Christina Thirlwell in
Google Scholar
PubMed Close
,
Debashis Sarker King’s College Hospital NHS Foundation Trust, London, UK

Search for other papers by Debashis Sarker in
Google Scholar
PubMed Close
,
Juan W Valle Institute of Cancer Sciences, University of Manchester/The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Juan W Valle in
Google Scholar
PubMed Close
, and
Tim Meyer Department of Oncology, Royal Free London NHS Foundation Trust, London, UK
UCL Cancer Institute, UCL, London, UK

Search for other papers by Tim Meyer in
Google Scholar
PubMed Close

-specific multi-gene transcripts (NET-test) ( Modlin et al. 2014 ), cfDNA and CTCs ( Khan et al. 2016 ), but further work is required to prospectively validate these markers before they can be used to select patients for chemotherapy ( Modlin et al. 2014

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-16-0099
Volume/Issue:
Volume 23: Issue 7
Free access
Enzo Lalli Université Côte d’Azur, Valbonne, France
CNRS UMR7275, Valbonne, France
NEOGENEX CNRS International Associated Laboratory, Valbonne, France
Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France

Search for other papers by Enzo Lalli in
Google Scholar
PubMed Close
and
Michaela Luconi Department of Experimental and Clinical Biomedical Sciences ‘Mario Serio’, University of Florence, Florence, Italy

Search for other papers by Michaela Luconi in
Google Scholar
PubMed Close

exosome miR-483-5p importance in metastatic ACC. Circulating cell-free DNA (cfDNA) and cell-free tumor DNA (ctDNA) Finally, the liquid biopsy can also provide circulating cfDNA, derived from non-tumoral and tumoral cells (ctDNA). The exact

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-17-0440
Volume/Issue:
Volume 25: Issue 2
Free access